K

Karyopharm Therapeutics

Develops nuclear export–inhibiting cancer therapies

Regional Business Director

Field SalesConfirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • A bachelor's degree is required.
  • At least 8 years of pharmaceutical sales experience is required.
  • Significant experience in oncology or rare disease, including product launches, is required.
  • Knowledge of retail, hospital, and managed care environments is required.

Responsibilities

  • Develop field sales plans and lead a regional team of field sales representatives.
  • Allocate the total regional sales budget and control expenses to meet or exceed business objectives.
  • Coordinate with Market Access and Medical Affairs functions at the regional level.
  • Understand key market drivers and business dynamics and provide those insights cross-functionally.
  • Teach, train, and coach sales professionals regarding product and disease-state knowledge.
  • Identify training needs and communicate them to the sales training team.
  • Ensure strong execution of commercial initiatives at the field level, recognize outstanding performance, and take action to improve behaviors and drive performance when needed.
  • Travel with sales representatives to key accounts as needed.
  • Identify, recruit, and retain top talent to fill vacant sales positions.
  • Collaborate with sales training to design programs for launch meetings, plans of action, and other sales training and planning meetings.
  • Foster relationships with Key Opinion Leaders, physician networks, and other industry contacts.
  • Oversee compliance by the field sales team with company policies and legal and regulatory guidelines.
  • Collaborate with the brand team, providing field-level insights to help influence and drive brand strategy.

Desired Qualifications

  • At least 2 years of pharmaceutical field sales management experience at a regional level is preferred.

About the Company

Karyopharm Therapeutics

Develops nuclear export–inhibiting cancer therapies

Karyopharm Therapeutics discovers, develops, and commercializes cancer medicines, focusing on hematologic malignancies and solid tumors. Its therapies inhibit nuclear export in cancer cells, keeping tumor-suppressor proteins in the nucleus to trigger cancer cell death and slow tumor growth. The company emphasizes a single core mechanism—nuclear export inhibition—supported by proprietary drugs and in-house development plus collaborations. Its goal is to improve patient outcomes by delivering targeted, mechanism-based therapies and expanding research partnerships.

Company size
201-500
Company stage
IPO
Headquarters
Newton, MA
Founded
2008

Recently Posted Jobs

Explore more opportunities at Karyopharm Therapeutics

See more jobs